Li SY - Search Results

1

Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12.

Zhang H, Wang Y, Wang QT, Sun SN, Li SY, Shang H, He YW. Zhang H, et al. Among authors: li sy. Front Cell Dev Biol. 2020 Mar 27;8:205. doi: 10.3389/fcell.2020.00205. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32292785 Free PMC article.

2

[6]-gingerol: a novel AT₁ antagonist for the treatment of cardiovascular disease.

Liu Q, Liu J, Guo H, Sun S, Wang S, Zhang Y, Li S, Qiao Y. Liu Q, et al. Planta Med. 2013 Mar;79(5):322-6. doi: 10.1055/s-0032-1328262. Epub 2013 Mar 11. Planta Med. 2013. PMID: 23479389

3

Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Wang Y, Sun SN, Liu Q, Yu YY, Guo J, Wang K, Xing BC, Zheng QF, Campa MJ, Patz EF Jr, Li SY, He YW. Wang Y, et al. Among authors: li sy. Cancer Discov. 2016 Sep;6(9):1022-35. doi: 10.1158/2159-8290.CD-15-1412. Epub 2016 Jun 13. Cancer Discov. 2016. PMID: 27297552 Free PMC article.

4

Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.

Zhang Z, Jiang J, Wu X, Zhang M, Luo D, Zhang R, Li S, He Y, Bian H, Chen Z. Zhang Z, et al. Front Med. 2019 Feb;13(1):57-68. doi: 10.1007/s11684-019-0683-y. Epub 2019 Feb 5. Front Med. 2019. PMID: 30721445

5

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.

Wang QT, Nie Y, Sun SN, Lin T, Han RJ, Jiang J, Li Z, Li JQ, Xiao YP, Fan YY, Yuan XH, Zhang H, Zhao BB, Zeng M, Li SY, Liao HX, Zhang J, He YW. Wang QT, et al. Among authors: li z, li jq, li sy. Cancer Immunol Immunother. 2020 Jul;69(7):1375-1387. doi: 10.1007/s00262-020-02496-w. Epub 2020 Feb 20. Cancer Immunol Immunother. 2020. PMID: 32078016 Clinical Trial.

6

Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?

Lu L, Jiang J, Zhan M, Zhang H, Wang QT, Sun SN, Guo XK, Yin H, Wei Y, Liu JO, Li SY, Li Y, He YW. Lu L, et al. Among authors: li y, li sy. Hepatology. 2021 Jan;73(1):414-421. doi: 10.1002/hep.31279. Hepatology. 2021. PMID: 32299136 Review. No abstract available.

7

Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?

Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, Li SY, Li Y, He YW. Lu L, et al. Among authors: li y, li sy. Front Cell Dev Biol. 2020 Jul 17;8:677. doi: 10.3389/fcell.2020.00677. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32766256 Free PMC article.

8

Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.

Lu L, Jiang J, Zhan M, Zhang H, Wang QT, Sun SN, Guo XK, Yin H, Wei Y, Li SY, Liu JO, Li Y, He YW. Lu L, et al. Among authors: li y, li sy. Hepatology. 2021 Feb;73(2):821-832. doi: 10.1002/hep.31502. Hepatology. 2021. PMID: 32767586 Review. No abstract available.

9

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, Li SY, Li Y, He YW. Lu L, et al. Among authors: li y, li sy. Sci China Life Sci. 2020 Dec;63(12):1833-1849. doi: 10.1007/s11427-020-1859-y. Epub 2020 Dec 1. Sci China Life Sci. 2020. PMID: 33355886 Free PMC article. Review.

10

Clinically approved combination immunotherapy: Current status, limitations, and future perspective.

Lu L, Zhan M, Li XY, Zhang H, Dauphars DJ, Jiang J, Yin H, Li SY, Luo S, Li Y, He YW. Lu L, et al. Among authors: li y, li xy, li sy. Curr Res Immunol. 2022 Jun 3;3:118-127. doi: 10.1016/j.crimmu.2022.05.003. eCollection 2022. Curr Res Immunol. 2022. PMID: 35676925 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,436 results

Search Page